Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationScand. J. Infect. Dis. 1994, 26(4):393-7
AbstractChlamydia pneumoniae is a newly recognized common cause of respiratory tract infections. The aim of this study was to examine its prevalence in Iceland. The study was based on 1020 serum samples from individuals 0-99 years old. The samples were divided into 10-year age groups. IgG and IgM antibodies were determined with microimmunofluorescence assay. An IgG titer > or = 32 and IgM titer > or = 16 were considered positive. The prevalence of positive IgG titer in the study population was 53 +/- 16% (mean +/- SD, age group range 14-66%). Neither seasonal nor gender-based difference in IgG antibody prevalence was demonstrated. It was lowest in the youngest group, 0-9 years old (p < 0.001), but rose linearly to age 70 (p < 0.005). 34 samples were IgM positive on initial testing; most from the older age groups. 12 were rheumatoid factor positive as well. After treatment with caprine antihuman IgG antibodies all became negative. The prevalence of C. pneumoniae infections is high in Iceland according to these results and similar to that in neighbouring countries. The presence of IgM rheumatoid factor may cause false positive tests for pathogen-specific IgM by immune complex binding with pathogen-specific IgG, thereby requiring its removal before testing.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- [Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards].
- Authors: Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, Numazaki K, Chiba S, Yamazaki T, Sasaki N, Kaku M, Shimada J, Iwasaki E, Baba M, Koori Y, Aihara M, Chikumi H, Kosaba S, Nonaka Y, Ouchi K, Yamamoto T, Kashiwagi S, Kawayama T, Ohizumi K, Nagai H
- Issue date: 1996 Aug
- [Detection of serum Chlamydia pneumoniae antibodies and analysis of epidemiologic data in 5 years].
- Authors: Cui J, Yan W, Ni A, Kong L, Chen L
- Issue date: 2014 Apr 1
- Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor.
- Authors: Verkooyen RP, Hazenberg MA, Van Haaren GH, Van Den Bosch JM, Snijder RJ, Van Helden HP, Verbrugh HA
- Issue date: 1992 May
- Detection of serum antibodies against Chlamydia pneumoniae by ELISA.
- Authors: Numazaki K, Ikebe T, Chiba S
- Issue date: 1996 Jun
- Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection.
- Authors: Kutlin A, Tsumura N, Emre U, Roblin PM, Hammerschlag MR
- Issue date: 1997 Mar